Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) intends to support the continuation of the Childhood Cancer Survivor Study (CCSS) that investigates the long-term morbidity and mortality associated with cancer treatments. The CCSS represents a multi-institutional, multidisciplinary collaborative research resource that currently has health-related data from 38,000 or more 5-year survivors of pediatric and adolescent cancer patients with a comparison sibling control cohort. The objectives are to use the resources to conduct cancer risk assessments, observational and intervention-based research studies associated with long-term outcomes across the life span of survivors with the intent of improving cancer treatments. • The study aims to obtain additional age-related longitudinal information from the current cohort of survivors and to include pediatric cancer survivors receiving modern therapies. • The goal of the CCSS is to serve as a data resource and a biorepository for researchers. • The application will be peer-reviewed, and only meritorious applications will be considered for funding. • This is a non-competitive funding opportunity intended to fund a single award to the current recipient of the Childhood Cancer Survivor Study.